HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma

94Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Cutaneous T-cell lymphoma (CTCL) may present with eczematous lesions, mycosis fungoides (MF), or as exfoliative erythroderma with circulating atypical cells, Sezary syndrome (SS). The 'malignant' T cells are epidermotropic and clonal, but whether they respond to antigen stimulation is unknown. Because CD4+ lymphocytes recognize antigen presented by histocompatibility locus antigen (HLA) class II molecules, and HLA associations have been found in autoimmune skin diseases, we determined by allele-specific oligonucleotide typing whether HLA-DR or DQ alleles were associated with CTCL and its two variants MF (n = 47) and SS (n = 23). Phenotypic frequencies were compared by chi-square and Fisher exact test, and p values were corrected independently for either 12 DR or 15 DQ alleles. HLA-DR5, previously associated with MF, was significantly increased in all 70 CTCL patients (31.5%) versus controls (11%) (uncorrected p value [p(nc)] = 0.000038, odds ratio [OR] = 3.9, 1.9

Cite

CITATION STYLE

APA

Jackow, C. M., Mc Ham, J. B., Friss, A., Alvear, J., Reveille, J. R., & Duvic, M. (1996). HLA-DR5 and DQB1*03 class II alleles are associated with cutaneous T-cell lymphoma. Journal of Investigative Dermatology, 107(3), 373–376. https://doi.org/10.1111/1523-1747.ep12363352

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free